Our results also show that the pathway experiences significant allelic losses and its expression is downregulated in colon adenocarcinoma, with PIWIL2 having the highest percentage of deletions and allelic losses within the pathway (Fig. 1). This evidence concerns the gene PIWIL2 and colon adenocarcinoma.